Drug:
Reaction: SKIN EXFOLIATION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940086 |
US |
55 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 2 | 26940503 |
US |
43 | 2 |
Pruritus, Dry skin, Skin exfoliation, Sleep disorder, |
||||
DUPILUMAB, |
||||
| 3 | 26941125 |
US |
35 | 1 |
Skin exfoliation, Injection site erythema, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 4 | 26941300 |
US |
1 | |
Pruritus, Skin fissures, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, |
||||
| 5 | 26942118 |
US |
2 | |
Eczema, Erythema, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 6 | 26942464 |
EU |
69 | |
Skin exfoliation, |
||||
DAPAGLIFLOZIN, |
||||
| 7 | 26943435 |
GB |
||
Skin exfoliation, |
||||
TOPIRAMATE, |
||||
| 8 | 26943487 |
US |
59 | 1 |
Loss of consciousness, Skin exfoliation, Drug ineffective, Arthralgia, Pain in extremity, Fingerprint loss, Skin erosion, Headache, Rash, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 9 | 26943600 |
US |
85 | 2 |
Sleep disorder, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 10 | 26943623 |
US |
28 | 2 |
Skin exfoliation, Rash, Skin fissures, |
||||
DUPILUMAB, |
||||
| 11 | 26943712 |
US |
||
Dysphagia, Skin exfoliation, |
||||
TALQUETAMAB, |
||||
| 12 | 26944141 |
US |
33 | 1 |
Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 13 | 26944760 |
CA |
69 | 2 |
Cough, Injection site pruritus, Skin exfoliation, |
||||
TOCILIZUMAB-AAZG, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
| 14 | 26944832 |
69 | ||
Skin exfoliation, |
||||
DAPAGLIFLOZIN, |
||||
| 15 | 26944993 |
US |
11 | 1 |
Dry skin, Skin exfoliation, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 16 | 26944996 |
US |
62 | 2 |
Dyspnoea, Nasopharyngitis, Dry skin, Skin exfoliation, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 17 | 26945457 |
EU |
75 | 2 |
Acute kidney injury, Lactic acidosis, Tubulointerstitial nephritis, Skin exfoliation, Dermatitis allergic, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, LINEZOLID, OXACILLIN, OXACILLIN SODIUM, AMIKACIN, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, MEROPENEM, |
||||
| 18 | 26945977 |
US |
2 | |
Skin exfoliation, Eye swelling, Dizziness, Rash, |
||||
ABALOPARATIDE, |
||||
| 19 | 26934296 |
US |
25 | 2 |
Dry skin, Injection site pain, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 20 | 26934589 |
US |
20 | 2 |
Pruritus, Dry skin, Skin exfoliation, Off label use, |
||||
DUPILUMAB, |
||||
| 21 | 26934877 |
US |
52 | 2 |
Pruritus, Dry skin, Skin exfoliation, Insomnia, |
||||
DUPILUMAB, |
||||
| 22 | 26935056 |
BR |
2 | |
Skull fracture, Haemorrhoids, Carcinoembryonic antigen increased, Liver injury, Metastasis, Metastases to bone, Metastases to liver, Metastases to spine, Metastases to thorax, Metastases to thyroid, Breast cancer metastatic, Metastases to liver, Haemorrhage, Skin fissures, Face injury, Dry throat, Dry skin, Rectocele, Nasal dryness, Vulvovaginal dryness, Skin exfoliation, Nasal discomfort, Contusion, Vascular rupture, Clavicle fracture, Panic attack, Blood oestrogen decreased, Skin disorder, Skin atrophy, Pain, Injury, Bone neoplasm, Limb injury, Peripheral swelling, Skin discolouration, Hypokinesia, Movement disorder, Limb discomfort, Muscular weakness, Lymphadenopathy, Stress, Erythema, Feeling abnormal, Gastrooesophageal reflux disease, Gait disturbance, Quality of life decreased, Rhinitis, Fatigue, Bone pain, Abdominal pain upper, PIK3CA-activated mutation, Hepatic mass, Nodule, Brain fog, Weight decreased, Insomnia, Greater trochanteric pain syndrome, Dry eye, Urinary tract infection, Arthralgia, Rash macular, Pain in extremity, Epistaxis, Alopecia, Hypersensitivity, Haematoma, Pruritus, Erythema, Tumour marker increased, Injection site swelling, Drug intolerance, Dizziness, Vomiting, Head discomfort, Malaise, Constipation, Polyp, Retching, Nausea, Dehydration, Sinusitis, Eating disorder, Thermal burn, Skin lesion, Hiatus hernia, Sensory loss, Drug ineffective, Needle issue, |
||||
FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, PANTOPRAZOLE, ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ALPELISIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CLONAZEPAM, EXEMESTANE, |
||||
| 23 | 26935088 |
US |
49 | 1 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 24 | 26935112 |
US |
62 | 2 |
Rash, Erythema, Skin fissures, Skin exfoliation, Dry skin, Skin swelling, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OCTOCRYLENE, AVOBENZONE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, LUBIPROSTONE, RIMEGEPANT SULFATE, SERTRALINE HYDROCHLORIDE, VITAMIN C, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 25 | 26935427 |
US |
27 | 1 |
Skin haemorrhage, Skin exfoliation, Sleep disorder, Therapeutic product effect decreased, Therapeutic product effect decreased, Pruritus, Skin weeping, Skin fissures, Dry skin, |
||||
UPADACITINIB, DUPILUMAB, |
||||
| 26 | 26935617 |
US |
52 | 1 |
Dry skin, Skin fissures, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, ROSUVASTATIN CALCIUM, TAMSULOSIN HYDROCHLORIDE, |
||||
| 27 | 26935703 |
US |
61 | 2 |
Metastases to central nervous system, Breast cancer, Malignant neoplasm progression, Pneumonia, Confusional state, Metastases to meninges, Hypercalcaemia, Neuropathy peripheral, Carcinoembryonic antigen increased, Mitral valve thickening, Tricuspid valve incompetence, General physical health deterioration, Impaired work ability, Metastases to liver, Metastases to bone, Metastases to lung, Metastases to lymph nodes, Fatigue, Decreased appetite, Hepatic enzyme increased, Oedema peripheral, Weight decreased, Blood cholesterol increased, Asthenia, Lethargy, Feeling cold, Hilar lymphadenopathy, Drug intolerance, Dry skin, Oesophagitis, Radiation associated pain, Constipation, Taste disorder, Haemorrhoidal haemorrhage, Pollakiuria, Pain, Palpitations, Depression, Cough, Pyrexia, Incontinence, Aphasia, Crying, Anhedonia, Transaminases increased, Spinal pain, Stomatitis, Hot flush, Dyspepsia, Dizziness, Insomnia, Alopecia, Burning sensation, Diplopia, Hepatomegaly, Cholelithiasis, Pleural effusion, Lymphadenopathy mediastinal, Bone lesion, Vitamin D decreased, Monocyte count decreased, Blood chloride decreased, Blood urea decreased, Red blood cell count decreased, Alanine aminotransferase increased, Haematocrit decreased, Haemoglobin decreased, Blood albumin decreased, Mean cell haemoglobin decreased, Protein total decreased, Blood creatinine decreased, Blood sodium decreased, Blood calcium decreased, Lymphocyte count decreased, Lymphocyte count increased, Red cell distribution width increased, Carbohydrate antigen 15-3 increased, Blood calcium increased, Mean cell haemoglobin increased, Blood cholesterol increased, Mean cell volume increased, Blood triglycerides increased, Glycosylated haemoglobin increased, Low density lipoprotein increased, Non-high-density lipoprotein cholesterol increased, White blood cell count increased, Blood glucose increased, Blood alkaline phosphatase increased, Aspartate aminotransferase increased, Carbohydrate antigen 27.29 increased, Monocyte count increased, Platelet count increased, Mean cell haemoglobin concentration increased, Blood bilirubin increased, Neutrophil count increased, Prothrombin time prolonged, Urobilinogen urine increased, Protein urine present, Lung infiltration, Aortic valve sclerosis, Mitral valve calcification, Skin exfoliation, |
||||
EVEROLIMUS, LETROZOLE, LETROZOLE TABLETS, FAMOTIDINE, FULVESTRANT, FULVESTRANT, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ALPRAZOLAM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ATENOLOL, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, EXEMESTANE, DENOSUMAB, PALBOCICLIB, ALPRAZOLAM, ALPRAZOLAM, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, ESCITALOPRAM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, GADOTERATE MEGLUMINE, GADOTERATE MEGLUMINE, FOLIC ACID, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, MORPHINE SULFATE, FERROUS SULFATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, |
||||
| 28 | 26935721 |
GB |
||
Skin exfoliation, |
||||
TOPIRAMATE, |
||||
| 29 | 26935756 |
US |
31 | 1 |
Pruritus, Conjunctivitis, Skin haemorrhage, Dry skin, Skin exfoliation, |
||||
TRALOKINUMAB-LDRM, METHYLPHENIDATE HYDROCHLORIDE, PIMECROLIMUS, CYCLOSPORINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 30 | 26935990 |
US |
31 | 1 |
Dry skin, Scratch, Skin haemorrhage, Skin fissures, Skin weeping, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 31 | 26936017 |
US |
4 | 1 |
Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation, Haemorrhage, |
||||
DUPILUMAB, |
||||
| 32 | 26936286 |
CO |
48 | 2 |
Hyperbilirubinaemia, Acne, Rash, Skin exfoliation, Skin burning sensation, |
||||
PANITUMUMAB, |
||||
| 33 | 26936336 |
US |
55 | 2 |
Skin exfoliation, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, TIOTROPIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, MONTELUKAST SODIUM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HYDROXYCHLOROQUINE, |
||||
| 34 | 26936356 |
US |
67 | 2 |
Asthenopia, Dry skin, Skin exfoliation, Skin fissures, Skin hyperpigmentation, Visual impairment, Erythema, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 35 | 26936466 |
CN |
87 | 1 |
Oedema, Blister, Rash, Pruritus, Pain, Off label use, Skin exfoliation, Skin weeping, Pigmentation disorder, |
||||
BEVACIZUMAB, |
||||
| 36 | 26936516 |
EU |
65 | 2 |
Pain of skin, General physical health deterioration, Influenza like illness, Pruritus, Skin exfoliation, Skin hyperpigmentation, Stevens-Johnson syndrome, Skin toxicity, Renal impairment, Tumour marker increased, |
||||
BEVACIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, CISPLATIN, |
||||
| 37 | 26936775 |
US |
71 | 2 |
Eczema, Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 38 | 26937139 |
GB |
1 | |
Skin exfoliation, Erythema, Application site pain, Eye swelling, Skin irritation, Suspected off label use, |
||||
MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), |
||||
| 39 | 26937346 |
EU |
65 | 2 |
Renal impairment, Tumour marker increased, Pain of skin, General physical health deterioration, Influenza like illness, Pruritus, Skin exfoliation, Skin hyperpigmentation, Stevens-Johnson syndrome, Skin toxicity, |
||||
BEVACIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, CISPLATIN, |
||||
| 40 | 26937915 |
US |
1 | |
Dry skin, Skin exfoliation, Pruritus, Dry eye, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ERGOCALCIFEROL, |
||||
| 41 | 26938583 |
US |
||
Skin exfoliation, |
||||
BRENSOCATIB, |
||||
| 42 | 26938596 |
US |
2 | |
Nausea, Blood pressure increased, Rash, Skin exfoliation, Headache, |
||||
BRENSOCATIB, PREDNISONE, TEZEPELUMAB-EKKO, AZELASTINE, NASAL, SODIUM CHLORIDE, SALINE, SALINE NASAL SPRAY, (SALINE), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, LOSARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESCITALOPRAM, VIBEGRON, PANTOPRAZOLE, EVOLOCUMAB, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, METHOCARBAMOL, METHOCARBAMOL TABLETS, CALCIUM, BIOTIN, CEFDINIR, ZOLEDRONIC ACID, |
||||
| 43 | 26931466 |
US |
50 | 2 |
Dry skin, Skin exfoliation, Skin fissures, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 44 | 26931478 |
US |
51 | 1 |
Rash papular, Therapeutic product effect decreased, Food allergy, Inflammation, Drug interaction, Pustule, Oral pruritus, Skin exfoliation, Skin discharge, Scratch, Frustration tolerance decreased, Psoriasis, |
||||
ADALIMUMAB, ADALIMUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, RESMETIROM, VITAMIN C, |
||||
| 45 | 26931625 |
US |
50 | 2 |
Pruritus, Peripheral swelling, Skin exfoliation, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 46 | 26931628 |
US |
1 | |
Erythema, Dermatitis, Eczema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 47 | 26932093 |
US |
4 | 2 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 48 | 26932099 |
US |
51 | 1 |
Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 49 | 26932266 |
US |
1 | |
Skin exfoliation, Drug ineffective, |
||||
DUPILUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, LATANOPROST, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DICLOFENAC SODIUM, |
||||
| 50 | 26932372 |
US |
24 | 1 |
Pruritus, Dry skin, Skin exfoliation, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 51 | 26932395 |
US |
81 | 2 |
Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 52 | 26932597 |
US |
44 | 2 |
Skin fissures, Skin swelling, Vision blurred, Skin exfoliation, Rash, |
||||
DUPILUMAB, PIMECROLIMUS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 53 | 26932612 |
US |
89 | 2 |
Scab, Pruritus, Skin exfoliation, Dermatitis atopic, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 54 | 26932677 |
US |
1 | |
Pruritus, Sleep disorder due to a general medical condition, Skin fissures, Skin exfoliation, Haemorrhage, Skin weeping, |
||||
DUPILUMAB, |
||||
| 55 | 26932712 |
US |
52 | 1 |
Pruritus, Dry skin, Skin exfoliation, Product use in unapproved indication, |
||||
DUPILUMAB, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, RUXOLITINIB, |
||||
| 56 | 26932713 |
US |
2 | |
Skin exfoliation, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMMONIUM LACTATE, CELECOXIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, FLUCONAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, HYDROCHLOROTHIAZIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LISINOPRIL, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 57 | 26932791 |
US |
69 | 2 |
Skin ulcer, Pain, Photopsia, Injection site pain, Skin weeping, Skin exfoliation, Scab, |
||||
DUPILUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, FAMOTIDINE, FISH OIL, IRON, FOLATE, AVACINCAPTAD PEGOL, ESOMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, PROMETHAZINE HYDROCHLORIDE, ZOLEDRONIC ACID, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, PYRITHIONE ZINC, ERGOCALCIFEROL, VITAMIN E, |
||||
| 58 | 26933302 |
US |
29 | 1 |
Dry skin, Skin exfoliation, Eye pruritus, |
||||
DUPILUMAB, |
||||
| 59 | 26933305 |
US |
65 | 1 |
Eczema, Skin exfoliation, Dry skin, Pruritus, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 60 | 26933406 |
US |
54 | 1 |
Dry skin, Pruritus, Skin exfoliation, Sleep disorder, |
||||
DUPILUMAB, |
||||
| 61 | 26933503 |
US |
32 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 62 | 26933580 |
US |
40 | 1 |
Dry skin, Pruritus, Skin exfoliation, Rash, |
||||
DUPILUMAB, |
||||
| 63 | 26933622 |
US |
69 | 2 |
Pruritus, Dry skin, Sinusitis, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 64 | 26933648 |
US |
31 | 1 |
Dry skin, Insomnia, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 65 | 26933693 |
US |
49 | 1 |
Pruritus, Skin exfoliation, Therapeutic product effect decreased, Dry skin, Sleep disorder due to a general medical condition, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 66 | 26933835 |
US |
3 | 1 |
Dry skin, Skin exfoliation, Skin fissures, Pruritus, Abdominal discomfort, Condition aggravated, Toothache, |
||||
DUPILUMAB, |
||||
| 67 | 26938134 |
53 | 2 | |
Skin reaction, Erythema, Pruritus, Skin irritation, Skin exfoliation, Product label issue, Oedema, Rash, Hypersensitivity, Alopecia, Product odour abnormal, Eye pruritus, |
||||
| 68 | 26926634 |
US |
26 | 1 |
Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 69 | 26926644 |
US |
6 | 1 |
Dry skin, Fear of injection, Skin exfoliation, Injection site pain, |
||||
DUPILUMAB, |
||||
| 70 | 26927250 |
US |
43 | 1 |
Pruritus, Skin fissures, Dry skin, Skin exfoliation, Dermatitis atopic, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ROFLUMILAST, |
||||
| 71 | 26927264 |
US |
68 | 2 |
Dermatitis allergic, Erythema, Skin exfoliation, Dry eye, Visual acuity reduced, Visual impairment, |
||||
DUPILUMAB, |
||||
| 72 | 26927737 |
US |
65 | 2 |
Dry skin, Skin fissures, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 73 | 26927898 |
BR |
1 | |
Plasma cell myeloma recurrent, Dry mouth, Skin exfoliation, Nail discolouration, Fingerprint loss, Ageusia, |
||||
BORTEZOMIB, DARATUMUMAB, TALQUETAMAB, DENOSUMAB, THALIDOMIDE, DARBEPOETIN ALFA, |
||||
| 74 | 26928407 |
US |
22 | 2 |
Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 75 | 26928809 |
US |
24 | |
Skin exfoliation, Eye pruritus, |
||||
DUPILUMAB, |
||||
| 76 | 26928980 |
US |
1 | |
Eczema, Skin exfoliation, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 77 | 26929236 |
US |
52 | 2 |
Swelling, Erythema, Skin exfoliation, Discharge, Skin hypopigmentation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 78 | 26929260 |
US |
69 | 2 |
Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 79 | 26929505 |
US |
||
Bronchiectasis, Insomnia, Feeling of body temperature change, Fatigue, Skin exfoliation, Nasopharyngitis, |
||||
BRENSOCATIB, |
||||
| 80 | 26929542 |
US |
1 | |
Urticaria, Pruritus, Skin exfoliation, Headache, |
||||
BRENSOCATIB, FEXOFENADINE HYDROCHLORIDE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, FLUTICASONE PROPIONATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 81 | 26929679 |
EU |
73 | 2 |
Syncope, Hypoacusis, Visual impairment, Tooth extraction, Fall, Back pain, Ear discomfort, Skin exfoliation, Periodontitis, |
||||
SITAGLIPTIN, |
||||
| 82 | 26929681 |
US |
55 | 2 |
Pain, Tooth disorder, Gingival recession, Dry skin, Skin exfoliation, |
||||
BRENSOCATIB, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, LISINOPRIL, HYDROCHLOROTHIAZIDE, MONTELUKAST, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, BIOTIN, CALCIUM, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, ERGOCALCIFEROL, DOXYCYCLINE, DOXYCYCLINE HYCLATE, AMOXICILLIN AND CLAVULANATE POTASSIUM, |
||||
| 83 | 26929788 |
GB |
69 | 2 |
Skin exfoliation, |
||||
DAPAGLIFLOZIN, |
||||
| 84 | 26929908 |
US |
47 | 2 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, Sleep disorder, |
||||
DUPILUMAB, |
||||
| 85 | 26929939 |
US |
35 | 2 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 86 | 26929965 |
US |
51 | 2 |
Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 87 | 26929994 |
US |
85 | 1 |
Eczema, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 88 | 26930031 |
US |
1 | |
Pain in extremity, Skin fissures, Erythema, Skin exfoliation, Dry skin, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, CARVEDILOL, EMPAGLIFLOZIN, FAMOTIDINE, FUROSEMIDE, LOSARTAN POTASSIUM, MONTELUKAST SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SOTALOL HYDROCHLORIDE, TIOTROPIUM BROMIDE, SPIRONOLACTONE, |
||||
| 89 | 26930125 |
GB |
||
Skin exfoliation, |
||||
TOPIRAMATE, |
||||
| 90 | 26930211 |
US |
57 | 2 |
Product adhesion issue, Application site irritation, Skin exfoliation, Urticaria, |
||||
CLONIDINE, CLONIDINE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 91 | 26930358 |
US |
27 | 1 |
Erythema, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 92 | 26930376 |
US |
81 | 2 |
Rash, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 93 | 26930708 |
US |
||
Dizziness, Skin exfoliation, |
||||
BRENSOCATIB, |
||||
| 94 | 26921458 |
GB |
66 | 2 |
Secondary progressive multiple sclerosis, Condition aggravated, Headache, Dry skin, Cough, Skin exfoliation, Pruritus, Dizziness, Urinary tract infection, Urinary tract infection, |
||||
SIPONIMOD, SIPONIMOD, |
||||
| 95 | 26921485 |
US |
||
Pruritus, Skin exfoliation, Dry skin, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 96 | 26921498 |
US |
68 | 2 |
Skin exfoliation, Pruritus, Dry skin, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALENDRONATE SODIUM, BAYER ASPIRIN EXTRA STRENGTH, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, EZETIMIBE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LEVOCETIRIZINE DIHYDROCHLORIDE, LORAZEPAM, MOMETASONE FUROATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CLOPIDOGREL, EVOLOCUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 97 | 26921691 |
US |
1 | |
Sunburn, Dry skin, Skin exfoliation, Ocular hyperaemia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 98 | 26921718 |
US |
23 | 1 |
Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 99 | 26921886 |
US |
11 | 2 |
Skin exfoliation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 100 | 26921900 |
US |
23 | 1 |
Pruritus, Skin exfoliation, Rash, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30